Who is the CEO of Evolus, Inc.?

The CEO of Evolus, Inc. is David Moatazedi.

What industry does Evolus, Inc. belong to?

Evolus, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Where is Evolus, Inc. headquartered?

Evolus, Inc. is headquartered at 520 Newport Center Drive, Newport Beach, CA, 92660, US.

What is the IPO date of Evolus, Inc.?

Evolus, Inc. went public on February 8, 2018.

How many employees does Evolus, Inc. have?

Evolus, Inc. has approximately 372 full-time employees.

Evolus, Inc.

EOLS•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$9.53

$-0.12(-1.24%)

Evolus, Inc. (EOLS) Company Profile & Overview

Explore Evolus, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Evolus, Inc. (EOLS) Company Profile & Overview

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

CEODavid Moatazedi

Contact Information

https://www.evolus.com

949 284 4555

520 Newport Center Drive, Newport Beach, CA, 92660

Company Facts

372 Employees

IPO DateFeb 8, 2018

CountryUS

Actively Trading

Frequently Asked Questions

;